iRhythm Holdings, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from iRhythm Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 96% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Of every $100 of net worth, $99 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 94% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
0.3×Over the last 3 years its own operating cash paid for 25% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Higher than 64% of Healthcare companies in United States.
Cash Locked Ratio
$12For every $100 of sales, $12 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $12 tied up three years earlier.
Less money tied up than 75% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$21Sales grew 82% in 3 years; of every extra $100 of sales, $21 became extra profit.
Higher than 52% of Healthcare companies in United States.
Asset Productivity Ratio
+82% / +128%In 3 years sales changed by +82% while total assets changed by +128%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
4.8×Debt due within a year is covered 4.8 times by its yearly operating cash.
Higher than 80% of Healthcare companies in United States.
Cash Cushion Ratio
−4%Debt, after subtracting cash, equals 4% of its market value (net debt).
Lower than 73% of Healthcare companies in United States.
Tangible Assets Ratio
100%Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 96% of Healthcare companies in United States.
Tangible Net Worth Ratio
99%Of every $100 of net worth, $99 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 94% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
iRhythm Holdings, Inc. made a loss over the last year. iRhythm Holdings, Inc. owes $0.83 for every $1 it owns. iRhythm Holdings, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossiRhythm Holdings, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
21.20The share price is 21.20 times iRhythm Holdings, Inc.'s book value per share, higher than 95% of Healthcare companies in United States.
Market cap
$3.9 BThe total market value of all of iRhythm Holdings, Inc.'s shares at today's price (share price × number of shares), larger than 82% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$186 MWhat iRhythm Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$5.64Net worth divided by the number of shares. The share price of $119.64 is 21.2 times this, which is the P/B above.
Return on equity (ROE)
-9.6%iRhythm Holdings, Inc. lost 9.6% of its shareholders' money over the last year, higher than 71% of Healthcare companies in United States.
Owes vs Owns
0.83×iRhythm Holdings, Inc. owes $0.83 for every $1 it owns (high), higher than 79% of Healthcare companies in United States.
Dividend yield
NoneiRhythm Holdings, Inc. does not currently pay a dividend.
Revenue growth
+26%Revenue rose 26% in the year to Dec 2025, and grew 22% a year on average over 3 years.
Profit growth
LossiRhythm Holdings, Inc. made a loss in each of the last two years.
Profit margin
-6.0%iRhythm Holdings, Inc. lost $6 for every $100 of revenue.
Interest cover
Not coverediRhythm Holdings, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtiRhythm Holdings, Inc. had $147 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For iRhythm Holdings, Inc.: $3.9 B ÷ $186 M (30 Jun 2026) = 21.2.
What is iRhythm Holdings, Inc.'s return on equity?
iRhythm Holdings, Inc. lost 9.6% of its shareholders' money over the last year, higher than 71% of Healthcare companies in United States.
How much does iRhythm Holdings, Inc. owe compared with what it owns?
iRhythm Holdings, Inc. owes $0.83 for every $1 it owns (high), higher than 79% of Healthcare companies in United States.
Does iRhythm Holdings, Inc. pay a dividend?
No. iRhythm Holdings, Inc. does not currently pay a dividend.
Is iRhythm Holdings, Inc.'s revenue growing?
Revenue rose 26% in the year to Dec 2025, and grew 22% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.